Spinal Cord Stimulation (SCS):
Relief tailored for your pain
Boston Scientific’s proven SCS therapy can be personalized to deliver the lasting relief you need — where and when you need it.
Our Spinal Cord Stimulation (SCS) is:
- Clinically proven to provide long-term relief from chronic pain
How does SCS work?
You feel pain when nerves send pain signals through your spinal cord to your brain.
SCS is designed to interrupt these signals so you don’t perceive them as pain.
A small device called a spinal cord stimulator is implanted under the skin.
Thin, flexible “leads” are connected to the stimulator and placed near specific nerves along the spinal cord.
The stimulator sends mild pulses through the leads to the nerves.
The pulses interrupt the pain signal on the way to the brain.
See how SCS works
Watch our animated SCS guide.
Spinal Cord Stimulator (SCS) System
The right therapy, right where you need it
Choose tingling or non-tingling stimulation, or a combination of both.
Personalized therapy gives you greater relief.
There are different kinds of SCS therapies.
Some therapies replace your pain with a tingling sensation. Others use a type of stimulation you don't feel at all.
With Boston Scientific, you can choose the therapy that works best for you --or use both at the same time.
The ability to deliver multiple therapies simultaneously* is unique to Boston Scientific SCS Systems and has been clinically proven to provide greater pain relief.1
In a major clinical study, patients using Boston Scientific's SCS therapies reported a greater improvement in their ability to do everyday activities† than patients in other studies using non-Boston Scientific SCS Systems.2,3,4
Pain isn’t static. It can change over time, and so can our SCS therapy. The WaveWriter Alpha SCS System uses technology that enables it to cover a wide area of the spine. This makes it easier to find your unique pain relief “target”—and to maintain therapy in the right spot if the target moves over time.
With four WaveWriter Alpha stimulators to chose from, your doctor will help you decide which one best suits your lifestyle needs.
The Right Option Now, And for the Future
The WaveWriter Alpha SCS System is available with either a rechargeable or non-rechargeable stimulator. Your doctor will help you decide which is right for your personal needs. Both options provide the same therapy choices, and both allow for full-body MRI, so you won't need to compromise your therapy preferences or future imaging options.
Significant Long-Term Relief
In another major clinical study, back pain patients reported a nearly 6-point drop in pain score, even after two years.5
Tens of thousands of people across the globe look to Boston Scientific SCS therapy for long-term, drug-free, FDA-approved pain relief.
More than 90% of Boston Scientific SCS trial participants reported a successful experience and opted to get the permanent implant.6
9 out of 10 Boston Scientific SCS patients said they were satisfied with their therapy and 95% would recommend it to others.6
Try your relief first
Before committing to SCS, find out if it will work for you by taking it for a “test drive” with a temporary trial system.
Real success stories
Talk to a real patient living with SCS therapy
Connect with real people living with pain and hear about their experience finding lasting relief by using a Boston Scientific solution.
Top 5 questions about SCS
Hear answers to the questions we get asked most often about SCS.
Learn about SCS with the mySCS™ app
Designed to help patients during their SCS trial, this free app also includes informative articles and resources on SCS for wherever you are on your journey.
Wondering if SCS may be right for you?
Take this quick quiz and find out. ⟶
*Paresthesia-free stimulation has been shown to be safe and effective in patients who have been treated successfully with paresthesia-inducing stimulation for at least 6 months.
†As measured by the Oswestry Disability Index at 3 months post implant.
References: 1. North, James, MD. WHISPER: A Multicenter, Prospective Randomized Controlled Trial Evaluating Subperception SCS at ≤ 1.2 kHz. Presentation at North American Neuromodulation Society (NANS), Las Vegas, NV, January 11-14, 2018. (N=70) 2. Wallace M. et al. Outcomes of a Prospective Randomized Controlled Trial Utilizing a Spinal Cord System Capable of Multiple Neurostimulation Modalities (COMBO). NANS Annual Meeting. January 2020 (N=89) 3. Kapural, Cong Yu, et al. Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: The SENZA-RCT Randomized Controlled Trial. Anesthesiology 2015; 123:851 -860 4. Deer, Timothy, et al. Success Using Neuromodulation With BURST (SUNBURST) Study: Results From a Prospective, Randomized Controlled Trial Using a Novel Burst Waveform. Neuromodulation: Technology at the Neural Interface. 21. 10.1111/ner.12698 5. Veizi E, Hayek SM, North J, et al. Spinal cord stimulation (SCS) with anatomically guided (3D) neural targeting shows superior chronic axial low back pain relief compared to traditional SCS—LUMINA Study. Pain Med. 2017;18(8):1534-1548. 6. Thomson SJ, Kruglov D, Duarte RV. A spinal cord stimulation service review from a single centre using a single manufacturer over a 7.5 year follow-up period. Neuromodulation. 2017;20(6):589-599. N=321
Results from clinical studies are not predictive of results in other studies. Results in other studies may vary.